These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21817854)

  • 41. Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis.
    Dean HJ; Fuller D; Osorio JE
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):373-88. PubMed ID: 12818623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques.
    Todorova B; Adam L; Culina S; Boisgard R; Martinon F; Cosma A; Ustav M; Kortulewski T; Le Grand R; Chapon C
    Sci Rep; 2017 Jun; 7(1):4122. PubMed ID: 28646234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD14+ antigen-presenting cells in human dermis are less mature than their CD1a+ counterparts.
    Angel CE; Lala A; Chen CJ; Edgar SG; Ostrovsky LL; Dunbar PR
    Int Immunol; 2007 Nov; 19(11):1271-9. PubMed ID: 17804688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.
    Guan X; Nishikawa M; Takemoto S; Ohno Y; Yata T; Takakura Y
    J Gene Med; 2010 Mar; 12(3):301-9. PubMed ID: 20084616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The skin as an immune organ.
    Salmon JK; Armstrong CA; Ansel JC
    West J Med; 1994 Feb; 160(2):146-52. PubMed ID: 8160465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting epidermal Langerhans cells by epidermal powder immunization.
    Chen D; Payne LG
    Cell Res; 2002 Jun; 12(2):97-104. PubMed ID: 12118944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delivering vaccines into the skin without needles and syringes.
    Partidos CD
    Expert Rev Vaccines; 2003 Dec; 2(6):753-61. PubMed ID: 14711359
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low-frequency ultrasound as a transcutaneous immunization adjuvant.
    Tezel A; Paliwal S; Shen Z; Mitragotri S
    Vaccine; 2005 May; 23(29):3800-7. PubMed ID: 15893617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvants in cutaneous vaccination: A comprehensive analysis.
    Oladejo M; Tijani AO; Puri A; Chablani L
    J Control Release; 2024 May; 369():475-492. PubMed ID: 38569943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [New options of influenza vaccination].
    Chlíbek R
    Cas Lek Cesk; 2010; 149(3):111-4. PubMed ID: 20429345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of skin-derived dendritic cells in CD8+ T cell priming following immunization with lentivectors.
    Furmanov K; Elnekave M; Lehmann D; Clausen BE; Kotton DN; Hovav AH
    J Immunol; 2010 May; 184(9):4889-97. PubMed ID: 20357252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Langerhans cells and dermal dendritic cells capture protein antigens in the skin: possible targets for vaccination through the skin.
    Sparber F; Tripp CH; Hermann M; Romani N; Stoitzner P
    Immunobiology; 2010; 215(9-10):770-9. PubMed ID: 20599290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
    Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization.
    Chen X; Fernando GJ; Crichton ML; Flaim C; Yukiko SR; Fairmaid EJ; Corbett HJ; Primiero CA; Ansaldo AB; Frazer IH; Brown LE; Kendall MA
    J Control Release; 2011 Jun; 152(3):349-55. PubMed ID: 21371510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mass vaccination: solutions in the skin.
    Glenn GM; Kenney RT
    Curr Top Microbiol Immunol; 2006; 304():247-68. PubMed ID: 16989274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA vaccines and intradermal vaccination by DNA tattooing.
    Oosterhuis K; van den Berg JH; Schumacher TN; Haanen JB
    Curr Top Microbiol Immunol; 2012; 351():221-50. PubMed ID: 21107792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
    Matsuo K; Hirobe S; Okada N; Nakagawa S
    Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutaneous vaccination: antigen delivery into or onto the skin.
    Weniger BG; Glenn GM
    Vaccine; 2013 Jul; 31(34):3389-91. PubMed ID: 23684830
    [No Abstract]   [Full Text] [Related]  

  • 59. Particle-based transcutaneous administration of HIV-1 p24 protein to human skin explants and targeting of epidermal antigen presenting cells.
    Rancan F; Amselgruber S; Hadam S; Munier S; Pavot V; Verrier B; Hackbarth S; Combadiere B; Blume-Peytavi U; Vogt A
    J Control Release; 2014 Feb; 176():115-22. PubMed ID: 24384300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy.
    Partidos CD; Muller S
    Cell Mol Life Sci; 2005 Jul; 62(13):1418-24. PubMed ID: 15818468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.